Photo - David Moore, executive vice president of US Operations at Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Credit: Aaron Schwartz / Pool via CNP/AdMedia

+ Favorites | Download Comp | Download Original

Are you sure?
Yes No

  • Photo Details
  • Caption: David Moore, executive vice president of US Operations at Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Credit: Aaron Schwartz / Pool via CNP/AdMedia
  • Event:

    Trump Announces Weight-Loss Drug Pricing Deal

     November 6, 2025
  • Location: Washington, District of Columbia, United States of America
  • Image Number: 9204887
  • Dimensions: 4000x2667 px
  • Photographer: Admedia

Allowed uses

FOR EDITORIAL USE ONLY including magazines, newspapers, and books w/ circulation up to 250k. Websites, blogs, presentations, TV, iPhone / iPad apps w/ unlimited electonic reproductions, and prints for personal use. Learn more.

Prohibited uses

Anything other than editorial use. Directly promoting a product or service, advertisements, commercials, electronic resale items such as templates and wallpapers, album covers, packaging, print on demand goods, and prints for resale are all prohibited uses.

Need more rights?

Although the standard license covers most uses, we know there are customers who need even more, such as unlimited print circulation. Contact us to purchase an Extended License and say goodbye to circulation restrictions!